The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global feminine hygiene products market was valued at US$ 26.5 Billion in 2022.
We expect the global feminine hygiene products market to exhibit a CAGR of 4.93% during 2023-2028.
The rising concerns regarding personal hygiene, along with the growing awareness towards adoption of biodegradable, compostable, and eco-friendly products, owing to the increasing environmental consciousness, are primarily driving the global feminine hygiene products market.
The sudden outbreak of the COVID-19 pandemic has led to the changing consumer inclination from conventional brick-and-mortar distribution channels towards online retail stores for the purchase of feminine hygiene products.
Based on the product type, the global feminine hygiene products market has been segmented into sanitary pads, panty liners, tampons, spray and internal cleaners, and others. Among these, sanitary pads currently hold the largest market share.
Based on the distribution channel, the global feminine hygiene products market can be bifurcated into supermarkets and hypermarkets, specialty stores, beauty stores and pharmacies, online stores, and others. Currently, supermarkets and hypermarkets account for the majority of the total market share.
On a regional level, the market has been classified into Asia Pacific, North America, Europe, Middle East and Africa, and Latin America, where Asia Pacific currently dominates the global market.
Some of the major players in the global feminine hygiene products market include Procter & Gamble, Edgewell Personal Care, Unicharm, Kimberly-Clark Corporation, Kao Corporation, etc.
Immunotherapy Drugs Market by Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at